Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06771037 · ClinicalTrials.gov registry record · NA
Use of tAN® in Alcohol Withdrawal Management
A NA study of Alcohol Withdrawal, sponsored by Erin Deneke.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06771037: Recruiting NA study of Alcohol Withdrawal, sponsored by Erin Deneke.
NCT06771037 is a NA study of Alcohol Withdrawal that is actively recruiting participants, run by Erin Deneke. The registered enrollment target is 60 participants, below the 78-participant average among 3 other Alcohol Withdrawal trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06771037, a NA study of Alcohol Withdrawal, is actively recruiting participants, sponsored by Erin Deneke.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being conducted to learn if Transcutaneous Auricular Neurostimulation (tAN®) may be effective in treating alcohol withdrawal syndrome. Transcutaneous Auricular Neurostimulation (tAN®) works by delivering small electrical stimulations to the Vagus and Trigeminal nerves. This study will be conducted over the course of five days. Participants will be enrolled within 24 hours of entering treatment for alcohol withdrawal management. A total of 60 individuals will be enrolled and randomly assigned to either active (treatment with the device + treatment as usual) or sham (treatment as usual) group. Data will be collected on alcohol craving, use of comfort medications, sleep, and mood.
Primary Outcome
Linear mixed effects models for repeated measurements will be used to evaluate the difference in changes in these primary outcomes between treatment and sham group. Mixed models take advantage of multiple measures from each individual, allowing for effects both between individuals and within each individual (e.g., across time). The CIWA-Ar is a 10-item scale measuring symptoms of alcohol withdrawal. The scores can range between 0-67. The total score is the sum of all scale items. Scores between
Conditions Studied
Interventions
- DEVICE Transcutaneous Auricular Neurostimulation (tAN)
Study Locations (1)
Pennsylvania
- Caron Treatment Centers - Wernersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT06771037 shows while recruiting
NCT06771037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 78-participant average among 3 other Alcohol Withdrawal trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Alcohol Withdrawal appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Auricular Neurostimulation (tAN) is the first listed.
NCT06771037 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06771037 about?
NCT06771037 is a clinical study titled "Use of tAN® in Alcohol Withdrawal Management". This research study is being conducted to learn if Transcutaneous Auricular Neurostimulation (tAN®) may be effective in treating alcohol withdrawal syndrome. Transcutaneous Auricular Neurostimulation (tAN®) works by delivering small electrical stimulations to the Vagus and Trigeminal nerves. This st...
What is the current status of trial NCT06771037?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-21. Estimated completion is 2027-07-01.
What conditions does trial NCT06771037 study?
This clinical trial studies the following conditions: Alcohol Withdrawal.
What interventions are being tested in trial NCT06771037?
The interventions under investigation include: Transcutaneous Auricular Neurostimulation (tAN) (DEVICE).
Who is sponsoring clinical trial NCT06771037?
This trial is sponsored by Erin Deneke, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06771037 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Withdrawal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI